EUVIMEDEUVIMED entdecken
Open Access

ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response

Kyle R Cron, Ping Fang, Oanh Pham, Julie Janes, John Brandenburg, William Lu, Jonathan Zhu, Bret Peterson, Sara Tribble, Haixing Kehoe, Anastasia Makarova, Alex Iannello und 6 weitere

Oncotarget · 2025

DOI: 10.18632/oncotarget.28769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, 2025. Verfasst von Kyle R Cron und 17 weiteren Autor:innen. Beteiligte Einrichtung: Actym Therapeutics, Berkeley, CA 94710, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Interleukin-15, Immunotherapy, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentInterleukin-15ImmunotherapyMembrane ProteinsNeoplasmsInterleukin-15 Receptor alpha SubunitAnimalsImmunity, InnateAdaptive ImmunityMiceHumansCell Line, TumorFemaleMice, Inbred C57BL

Stichwörter der Autor:innen

IL-15STINGbacterial vectormyeloid cellstumor microenvironment

Substanzen

Interleukin-15Membrane ProteinsInterleukin-15 Receptor alpha Subunit

Autor:innen und Institutionen

  • Actym Therapeutics, Berkeley, CA 94710, USA.

Zitieren

APA

Cron, K. R., Fang, P., Pham, O., Janes, J., Brandenburg, J., Lu, W., Zhu, J., Peterson, B., Tribble, S., Kehoe, H., Makarova, A., Iannello, A., Chan, J., Skoble, J., He, H., Rae, C., Thanos, C. D., & Udyavar, A. R. (2025). ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response. Oncotarget. https://doi.org/10.18632/oncotarget.28769

Vancouver

Cron KR, Fang P, Pham O, Janes J, Brandenburg J, Lu W, et al. ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response. Oncotarget. 2025. doi:10.18632/oncotarget.28769

BibTeX
@article{Cron2025,
  author = {Cron, Kyle R and Fang, Ping and Pham, Oanh and Janes, Julie and Brandenburg, John and Lu, William and Zhu, Jonathan and Peterson, Bret and Tribble, Sara and Kehoe, Haixing and Makarova, Anastasia and Iannello, Alex and Chan, Jean and Skoble, Justin and He, Hailey and Rae, Chris and Thanos, Christopher D and Udyavar, Akshata R},
  title = {ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response},
  journal = {Oncotarget},
  year = {2025},
  doi = {10.18632/oncotarget.28769}
}
Kostenlos starten →